Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pro Coxam 1500mg tablets
1001050A0CCACAH
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Pro Coxam 500mg tablets
1001050A0CCAAAJ
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Pro Coxam 625mg tablets
1001050A0CCABAA
|
Pro Coxam | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Solgar Glucosamine hydrochloride 1000mg tablets
1001050A0BLAAAI
|
Solgar (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Valupak Vegetarian Glucosamine hydrochloride 500mg tablets
1001050A0BNAAAJ
|
Valupak (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Vegetarian Glucosamine hydrochloride 750mg tablets
1001050A0BXAAAB
|
BR Pharm (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.